Leadership
CNS clinical research is our passion. Because of this we have brought together the finest leadership team of industry experts who specialize in central nervous system disorders. This elite teams provides best-in-class services by skillfully blending both scientific and operational excellence into every project we manage.
Gary Zammit, PhD - President and Chief Executive Officer
Gary Zammit, is the President & CEO of Clinilabs Drug Development Corporation, a full-service CRO that provides clinical drug development to industry, focusing on CNS therapeutics. Gary Zammit is a scientist and former academician who founded Clinilabs Drug Development Corporation in 2001, having the belief that there was an industry need for a specialty CNS CRO that could improve the way new drugs and medical devices are developed. Dr. Zammit is widely sought for his expertise in neuropsychiatric drug development. Gary has authored more than 230 original publications and 2 books, and has served as a reviewer and editor for well-known medical journals. He is committed to ensuring that Clinilabs Drug Development Corporation’s senior management remains involved in every project that we accept, so that clients have easy and immediate access to the leadership of a high-performance development team.
Eileen McAuley - Chief Operating Officer
Eileen McAuley has more than 25 years of clinical research experience, having occupied positions in operational and strategic leadership roles. She currently oversees Clinilabs Drug Development Corporation’s operations, and is responsible for the oversight of project management, monitoring services, data management, biostatistics, medical writing and our Phase 1 clinics. Most recently, Eileen served as Senior Vice President, Clinical Services, at Frontage Labs, a provider of Phase 1 clinical research and bioanalytic services. Prior to that, she was the COO at Integrium, a full service CRO for cardiovascular, metabolic, and dermatology trials.
Eileen began her career as a critical care nurse and progressed to serve in clinical operations roles of increasing responsibility, including roles as Director of Project Management and head of operations for specialty clinical organizations. She earned a master’s degree in public administration from Seton Hall University, with a focus on health policy and management. She received a Bachelor’s of science degree from Montclair State College in New Jersey.
Robert DunnMD, PhD - Chief Scientific Officer
Robert Dunn, MD, PhD, as the Chief Scientific Officer for Clinilabs. With two decades of experience in clinical development and neuroscience research, Bob is a prominent figure in the field of CNS research. He has directed and designed clinical studies in various indications ranging from Phase I to Phase IV. He has worked with key opinion leaders, vendors, and interdisciplinary teams on various neuroscience projects. Bob has expertise in psychiatric indications such as unipolar depression, schizophrenia, bipolar depression, anxiety, and autism. He has previously held positions at Pfizer, Forest Research Institute, and Forum Pharmaceuticals, and was also an Assistant Professor at Harvard Medical School. Bob has obtained his MD and PhD in Pharmacology and Physiology from the University of Chicago Pritzker School of Medicine. His ultimate goal is to provide innovative and effective solutions to people suffering from psychiatric and neurological illnesses.
Jerry Deptuch - Chief Information Officer
Jerry Deptuch is a seasoned Information Technology professional having achieved positions with increasing responsibility throughout his career. Jerry is committed to help set and lead the technology strategies of our organization in collaboration with the executive management team. With his hands-on approach, Jerry serves as an effective liaison between the technology department and the other business units within Clinilabs. Jerry is innovative in his approach to identify new technologies that can assist the organization in achieving its goals and objectives. Having a master’s degree in Mathematics, Jerry has a cost-effective approach in his methodologies to identify the resources needed to meet or exceed these goals and objectives.
As the Chief Information Officer, Jerry guides his team to create business value through technology, planning of business growth opportunities, and ensuring tech systems and procedures are in place to meet objectives while maintaining business efficiency and productivity at Clinilabs.
Christina Saulys - Vice President, Project Solutions
As Vice President of Project Solutions, Chris oversees all Core Laboratory Projects under the Data Services umbrella. She has over three decades of clinical research experience as a clinician and manager in roles at both site and CRO in phase I-IV trials. Chris joined Clinilabs’ first central scoring team in 2001 as a Registered Polysomnographic Technologist. During her tenure, Chris has used her unique blend of knowledge and determination to develop, motivate and inspire a diverse team that has contributed to over 260 clinical trials and the development of every major sleep therapeutic marketed since 2001.
Chris has developed special expertise in many types of electronic data collection methods, analysis tools and decentralized trial solutions. Leading with unparalleled global support and collaboration, she has worked to establish one of the most comprehensive databases of certified CNS sites and investigators in the world. Chris has extensive experience in neuro-diagnostics and holds certifications as a Clinical Research Associate and Project Manager. She has also held Executive leadership roles in Education and Quality Improvement, global Clinical Trial Management and Senior Project Management. Chris holds a Bachelor’s degree from the University of Nevada, Reno, and is licensed and Registered as a Polysomnographic Technologist (RPSGT) and Registered Sleep Technologist (RST).
Jeanine M. Falinski, MBA - Vice President, Strategy and Corporate Development
Ms. Jeanine Falinski, Head of Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from the LeBow College of Business at Drexel University. Jeanine joined Clinilabs in 2004 as a Manager of Subject Recruitment and continued on through positions of progressive responsibility including Senior Director of Marketing and Communications and Senior Director of Business Development. In 2014, she joined Evolution Research Group as Senior Director of Business Development and subsequently joined Artcraft Health, a marketing agency devoted to patient engagement and recruitment in clinical trials. In January of 2019, Jeanine returned to Clinilabs having gained valuable experience in other organizations. Today, Jeanine provides leadership to Clinilabs by spearheading business development, external affairs and corporate communication initiatives.
I have no ideology. My ideology is health.
I am not accustomed to saying anything with certainty after only one or two observations.
Drugs don’t work in patients who don’t take them.
One never notices what has been done; one can only see what remains to be done.
The reward for work well done is the opportunity to do more.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
The best way to predict the future is to invent it.
Good information is the best medicine.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
All truths are easy to understand once they are discovered; the point is to discover them.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
There is so much more to be done; the patients are waiting.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
One sometimes finds what one is not looking for.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
If you think compliance is expensive, try non-compliance.
The pace of discovery is going unbelievably fast.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.